// App-Quantinova.ai

3403 : The Outcomes Of Allogeneic Stem Cell Transplantation In Patients With Mixed Phenotype Acute Leukemia (MPAL) Are Comparable To Those In Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL): Results Of a Matched-Pair Analysis

Researchers

Presenter

  • Hiroaki Shimizu

Principal Investigators

  • Takayuki Saitoh

  • Shinichiro Machida

  • Shinichi Kako

  • Noriko Doki

  • Takehiko Mori

  • Toru Sakura

  • Yoshinobu Kanda

  • Heiwa Kanamori

  • Shuichi Miyawaki

  • Shinichiro Okamoto

Medical Centers

  • Department of Medicine and Molecular Science, Gunma University, Maebashi, Gunma, Japan

  • Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

  • Kanto Study Group for Cell Therapy, Tokyo, Japan

  • Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan

  • Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan

  • Division of Hematology, Department of Internal Medicine, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan

  • Division of Hematology, Tokyo Metropolitan Cancer and Infectious diseases Center, Tokyo, Japan

  • Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved